NR3C1 and Miyoshi myopathy: Furthermore, the combination of selinexor with dexamethasone induces synergy on several levels: retention of transcriptionally active glucocorticoid receptor in the nucleus, induction of glucocorticoid anti‐proliferative expression and activity leading to the inhibition of the mTOR pathway and to enhanced MM cancer cell death.32